Getting paid: New Part B drug pay models intended to boost quality would test providers
Will a radical shift in the way Medicare pays providers for Part B drugs improve patient care? That’s the question CMS seeks to answer with a five-year nationwide test of different payment models that the agency plans to start this fall.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.